Document:

Form of Class 6(B) Warrant

 EXHIBIT 4.1 
  

[Common Stock Purchase Warrant WS-[            ]] 
 [                        ]

  
 THIS WARRANT AND THE WARRANT SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN
ISSUED PURSUANT TO THE DEBTORS’ AND OFFICIAL COMMITTEE OF UNSECURED CREDITORS’ THIRD AMENDED REVISED JOINT PLAN OF REORGANIZATION OF FLEMING COMPANIES, INC. AND ITS FILING SUBSIDIARIES UNDER CHAPTER 11 OF THE UNITED STATES BANKRUPTCY CODE
CONFIRMED IN THE BANKRUPTCY CASES OF FLEMING COMPANIES, INC. AND CERTAIN OF ITS SUBSIDIARIES BY THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE, CASE NO. 03-10945 (MFW ) (JOINTLY ADMINISTERED). ANY WARRANT SHARES ISSUABLE UPON
EXERCISE HEREOF AND ANY INTEREST THEREIN IS EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY STATE AND LOCAL SECURITIES LAWS AND IS FREELY TRANSFERABLE PURSUANT TO SECTION 1145(A) OF THE BANKRUPTCY CODE. 
  
 NO WARRANTS AND NO WARRANT SHARES HELD BY AN UNDERWRITER OR AN AFFILIATE OF THE COMPANY MAY
BE SOLD, EXCHANGED OR OTHERWISE TRANSFERRED IN VIOLATION OF THE SECURITIES ACT OR STATE SECURITIES LAWS. ACCORDINGLY, THE COMPANY RECOMMENDS THAT POTENTIAL RECIPIENTS OF WARRANTS AND WARRANT SHARES CONSULT THEIR OWN COUNSEL CONCERNING WHETHER THEY
MAY FREELY TRADE SUCH SECURITIES. 
  

					
	No. [    ]	 	 	 	Right to Purchase [            ] shares of common stock of Core-Mark Holding Company, Inc.

  
 COMMON STOCK
PURCHASE WARRANT 
  
 CORE-MARK HOLDING COMPANY, INC.

  
 August 23, 2004 
  
 Core-Mark Holding Company, Inc., a Delaware corporation (the
“Company”), HEREBY CERTIFIES that, for value received, [                        ] (together with its
assigns, the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company at any time or from time to time during the Exercise Period, up to
[            ] shares (the “Warrant Shares”) of Common Stock of the Company, at a purchase price per share of $20.925 (such purchase price per share as adjusted from
time to time as herein provided is referred to herein as the “Exercise Price”). The Warrant Shares have been duly authorized and, when issued in accordance with the terms of the Warrant, shall be validly issued, and upon receipt by
the Company of the Exercise Price, fully paid and nonassessable. 
  
 This Warrant is one of the warrants (the “Warrants”) evidencing the right to purchase shares of Common Stock of the Company issued to the holders of the allowed Class 6(B) claims pursuant to the Debtors’ And Official
Committee Of Unsecured Creditors’ Third Amended Revised Joint Plan Of Reorganization Of Fleming Companies, Inc. And Its Filing Subsidiaries 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 
Under Chapter 11 of the United States Bankruptcy Code (the “Plan”) confirmed in the bankruptcy cases of Fleming Companies, Inc. and certain
of its subsidiaries by the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”), Case No. 03-10945 (MFW) (Jointly Administered). (A copy of the Plan is available upon request to the Company). The
Holder shall be entitled to all of the benefits and subject to all of the restrictions set forth in the Plan. 
  
 1. Definitions. 
  
 Capitalized terms used herein but not otherwise defined herein shall have the meanings provided for them in the Plan. As used herein, the following terms, unless the context otherwise requires, have the following respective meanings:

  

	 	(a)	“Company” means Core-Mark Holding Company, Inc. and any entity which shall succeed to, or assume the obligations of, the Company hereunder.

  

	 	(b)	“Common Stock” means (i) the Company’s Common Stock, par value $0.01 per share, as authorized on the Issue Date, (ii) any other capital stock of any class or
classes (however designated) of the Company, authorized on or after the date hereof, the holders of which shall have the right, without limitation as to amount per share, either to all or to a share of the balance of current dividends and
liquidating distributions after the payment of dividends and distributions on any shares entitled to preference in the payment thereof, and (iii) any other securities into which or for which any of the securities described in (i) or (ii) above may
be converted or exchanged pursuant to a plan of recapitalization, reorganization, merger, sale of assets or otherwise. 

  

	 	(c)	“Common Stock Equivalents” means any warrant, option, subscription or purchase right with respect to shares of Common Stock, any security convertible into,
exchangeable for, or otherwise entitling the holder thereof to acquire, shares of Common Stock or any warrant, option, subscription or purchase right with respect to any such convertible, exchangeable or other security. 

  

	 	(d)	“Excluded Securities” means (i) warrants or options that are outstanding as of the date hereof and warrants and options that may be granted in the future pursuant
to the (A) 2004 Core-Mark Holding Company, Inc. Long Term Incentive Plan, (B) 2004 Core-Mark Holding Company, Inc. Directors Incentive Plan, and (C) the Note and Warrant Purchase Agreement, dated as of August 20, 2004, among the Company and certain
of its subsidiaries, the purchasers identified therein and Wells Fargo Bank, N.A., as Administrative Agent, (ii) the Warrants, (iii) any securities issued pursuant to any agreement entered into by the Company or any of its subsidiaries for the
acquisition of another business (whether by stock purchase or assets purchase, merger or otherwise), and (iv) any securities issued pursuant to an underwritten public offering. 

  

	 	(e)	“Exercise Period” has the meaning specified in Section 18 hereof. 

  

 2 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

	 	(f)	“fair market value” per share of the Company’s Common Stock means: 

  

	 	(i)	If the Common Stock is traded on a national securities exchange, the Toronto Stock Exchange or admitted to unlisted trading privileges on such an exchange, or is listed on the
NASDAQ National Market, the fair market value shall be the weighted average intraday trading price of the Common Stock on such exchange or on the NASDAQ during the 20 trading days ending two trading days immediately preceding the effective date of
exercise or deemed exercise (including by net issue election) as reported by Bloomberg; however, if the weighted average intraday trading price is not available, then the fair market value shall be the average closing price (or if no sale is made,
the mean of the closing bid and asked prices) of the Common Stock on such exchange or on the NASDAQ for the 20 trading days ending two trading days immediately preceding the date of exercise or deemed exercise (including by net issue election);

  

	 	(ii)	If the Common Stock is not so listed or admitted to unlisted trading privileges, the fair market value shall be the average of the last bid and asked prices reported by the NASDAQ
(or if such reports are unavailable, by the National Quotation Bureau Incorporated or, if such reports are unavailable, the reports of the Over-the-Counter “pink sheets” or the Over-the-Counter Bulletin Board) for the 20 trading days
ending two trading days immediately preceding the effective date of exercise or deemed exercise (including by net issue election); and 

  

	 	(iii)	If the Common Stock is not so listed or admitted to unlisted trading privileges described in the foregoing clauses (i) and (ii) and bid and ask prices described in the foregoing
clauses (i) and (ii) are not reported, the fair market value shall be as determined as of a date not more than 90 days before the effective date of exercise or deemed exercise (including by net issue election) and shall be determined by:

  

	 	(A)	a reputable independent appraisal service selected by the Company for this purpose in the event that (x) fair market value is being calculated for any reason under this Agreement
(other than pursuant to Section 2.4), (y) fair market value is being calculated pursuant to Section 2.4 and a reputable independent appraisal service selected by the Company has not determined the fair market value of Common Stock during the
one-year prior to the effective date of exercise or deemed exercise (including any net issue election) or (z) fair market value is being calculated pursuant to Section 2.4 and the net issue election of Warrants involves underlying Common Stock that
represents one percent (1 %) or more of the Common Stock then outstanding, or 

  

 3 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

	 	(B)	by the Company’s Board of Directors for all other events not described in the foregoing clauses (x), (y) and (z) of the foregoing clause (A). 

  

	 	(a)	“Issue Date” means August 23, 2004. 

  

	 	(b)	“Majority Warrantholders” means the Holders of Warrants representing 50.1% of the shares of Common Stock obtainable upon exercise of such Warrants then outstanding.

  

	 	(c)	“Officer” means the Chairman of the Board, the President, any Vice President, the Chief Financial Officer or the Treasurer of the Company. 

 

	 	(d)	“Other Securities” means any stock other than Common Stock and other securities of the Company or any other Person which the Holders of the Warrants at any time
shall be entitled to receive, or shall have received, on the exercise of the Warrants, in lieu of or in addition to Common Stock, or which at any time shall be issuable or shall have been issued in exchange for or in replacement of Common Stock or
other securities pursuant to Section 4 or otherwise. 

  

	 	(e)	“Person” means any individual, corporation, partnership, joint venture, limited liability company, association, joint-stock company, trust, unincorporated
organization, government or any agency or political subdivision thereof or any other entity. 

  

	 	(f)	“Securities Act” means the Securities Act of 1933, as amended, or any successor federal statute, and the rules and regulations thereunder which shall be in effect
at the time. 

  

	 	(g)	“Warrant Agent” has the meaning set forth in Section 13. 

  

	 	(h)	“Warrant Shares” has the meaning specified in the first introductory paragraph hereof. 

  
 2. Exercise of Warrant. 
  
 2.1. Full Exercise. This Warrant may be exercised at any time during the Exercise Period in full by the Holder by surrender of this
Warrant, with the form of subscription at the end hereof duly executed by such Holder, to the Company at its principal office, or the Warrant Agent, as applicable, accompanied by payment, in cash or by certified or official bank check payable to the
order of the Company, in the amount obtained by multiplying the number of shares of Common Stock for which this Warrant is then exercisable by the Exercise Price then in effect. 
  
 2.2. Partial Exercise. This Warrant may be exercised at any time before its expiration in part by
surrender of this Warrant and payment of the Exercise Price then in effect in the manner and at the place provided in subsection 2.1, except that the 

  

 4 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 
amount payable by such Holder on such partial exercise shall be the amount obtained by multiplying (a) the number of shares of Common Stock designated by the
Holder in the subscription at the end hereof by (b) the Exercise Price then in effect. On any such partial exercise the Company, at the Holder’s expense, will forthwith issue and deliver to, or upon the order of, such Holder a new Warrant or
Warrants of like tenor, in the name of such Holder or as such Holder (upon payment by such Holder of any applicable transfer taxes) may request, calling in the aggregate on the face or faces thereof for the number of shares of Common Stock for which
such Warrant or Warrants may still be exercised. 
  
 2.3. Company Acknowledgment. The Company or the Warrant Agent, as applicable, will, at the time of the exercise of this Warrant, upon the request of the Holder hereof acknowledge in writing its continuing obligation to afford to such
Holder any rights to which such Holder shall continue to be entitled after such exercise in accordance with the provisions of this Warrant. If the Holder shall fail to make any such request, such failure shall not affect the continuing obligation of
the Company to afford to such Holder any such rights. 
  
 2.4. Net Issue Election. The Holder may elect to receive, without the payment by the Holder of any additional consideration, shares equal to the value of this Warrant or any portion hereof by the surrender of this Warrant or such
portion to the Company, at the office of the Company, with the net issue election notice annexed hereto duly executed. Thereupon, the Company shall issue to the Holder such number of fully paid and nonassessable shares of Common Stock as is computed
using the following formula: 
  
 X = Y x (A - B)

             A 
  
 where 
  

			
	 X =
	  	the total number of shares of Common Stock to be issued to the Holder pursuant to this Section 2.4.
	 Y =
	  	the number of shares of Common Stock covered by this Warrant in respect of which the net issue election is made pursuant to this Section 2.4.
	 A =
	  	the fair market value of one share of Common Stock.
	 B =
	  	the Exercise Price in effect under this Warrant at the time the net issue election is made pursuant to this Section 2.4.

  
 3. Delivery of Stock Certificates,
etc. on Exercise. As soon as practicable after the exercise of this Warrant in full or in part, and in any event within five (5) business days thereafter, the Company at its expense (including the payment by it of any applicable issue taxes)
will cause to be issued in the name of and delivered to the Holder hereof, or as such Holder (upon payment by such Holder of any applicable transfer taxes) may direct, a certificate or certificates for the number of fully paid and nonassessable
shares of Common Stock (or Other Securities) to which such Holder shall be entitled on such exercise, plus, in lieu of any fractional share to which such 

  

 5 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 
Holder would otherwise be entitled, cash equal to such fraction multiplied by the then current fair market value of one full share, together with any other
stock or other securities and property (including cash, where applicable) to which such Holder is entitled upon such exercise pursuant to Section 2 or otherwise. 
  
 4. Adjustment for Dividends in Other Stock, Property, etc.; Reclassification, etc. If, at any time or from time to time, the holders
of Common Stock (or Other Securities) in their capacity as such shall have received, or (on or after the record date fixed for the determination of shareholders eligible to receive) shall have become entitled to receive, without payment therefor,
other or additional stock or Other Securities or property (excluding cash) by way of dividend, spin-off, reclassification, recapitalization, combination of shares, similar corporate rearrangement or otherwise, then and in each such case the Holder
of this Warrant, shall be entitled to receive, upon the exercise hereof, the amount of stock and Other Securities and property (excluding cash) which such Holder would have been entitled to receive had the Holder been the holder of record of the
number of shares of Common Stock called for on the face of this Warrant and had thereafter, during the period from the date hereof to and including the date of such exercise, retained such shares and all such other or additional stock and Other
Securities and property (excluding cash) receivable by it as aforesaid during such period, giving effect to all adjustments called for during such period by Sections 5 and 6. 
  
 5. Adjustment for Reorganization, Consolidation. Merger, etc. 
  
 5.1. Reorganization, Consolidation, Merger, etc. If, at any time or from time to time, the Company
shall (a) effect a reorganization or reclassification of the Common Stock or Other Securities (other than a reorganization or reclassification to the extent that such reorganization or reclassification results in an adjustment in the Warrant Price
pursuant to Section 6 hereof), (b) consolidate with or merge into any other Person, or (c) transfer all or substantially all of its properties or assets to any other Person under any plan or arrangement contemplating the dissolution of the Company,
then, in each such case, the Holder of this Warrant, on the exercise hereof as provided in Section 2 at any time after the consummation of such reorganization, consolidation or merger or the effective date of such dissolution, as the case may be,
shall receive, in lieu of the Common Stock (or Other Securities) issuable on such exercise prior to such consummation or such effective date, the stock and Other Securities and property (including cash) to which such Holder would have been entitled
upon such consummation or in connection with such dissolution, as the case may be, if such Holder had so exercised this Warrant, immediately prior thereto, all subject to further adjustment thereafter as provided in Sections 4 and 6. 
  
 5.2. Dissolution. In the event of any dissolution of
the Company following the transfer of all or substantially all of its properties or assets, the Company, prior to such dissolution, shall at its expense deliver or cause to be delivered the stock and Other Securities and property (including cash,
where applicable) receivable by the Holders of the Warrants (net of the Exercise Price) after the effective date of such dissolution pursuant to this Section 5 to a bank or trust company having its principal office in the United States of America as
trustee for the Holders of the Warrants. 
  

 6 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 5.3. Continuation of Terms. Upon any reorganization, consolidation, merger or
transfer (and any dissolution following any transfer) referred to in this Section 5, this Warrant shall continue in full force and effect, subject to expiration in accordance with Section 18 hereof, and the terms hereof shall be applicable to the
shares of stock and Other Securities and property receivable on the exercise of this Warrant after the consummation of such reorganization, consolidation or merger or the effective date of dissolution following any such transfer, as the case may be,
and shall be binding upon the issuer of any such stock or Other Securities, including, in the case of any such transfer, the Person acquiring all or substantially all of the properties or assets of the Company, whether or not such Person shall have
expressly assumed the terms of this Warrant as provided in Section 7. 
  
 6.
Anti-Dilution Adjustment. 
  
 6.1.
General. The Exercise Price shall be subject to adjustment from time to time as hereinafter provided. Upon each adjustment of the Exercise Price, the Holder of this Warrant shall thereafter be entitled to purchase, at the Exercise Price
resulting from such adjustment, the number of shares obtained by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of shares purchasable pursuant hereto immediately prior to such adjustment and dividing the
product thereof by the Exercise Price resulting from such adjustment. 
  
 6.2. Exercise Price Adjustments. If and whenever after the date hereof the Company shall issue or sell any shares of its Common Stock (except for any issuance upon exercise of any Excluded Security in
accordance with the terms thereof or shares issued in transactions to which subsection 6.6 of this Warrant apply) for a consideration per share less than the fair market value of such Common Stock on the date of such issue or sale, or shall be
deemed under the provisions of this Section 6 to have effected any such issuance or sale, then, forthwith upon such issue or sale, the Exercise Price shall be reduced to the price (calculated to the nearest $0.000001) obtained by multiplying the
Exercise Price in effect immediately prior to the time of such issue or sale by a fraction, (x) the numerator of which shall be the sum of (i) the number of shares of Common Stock and Common Stock issuable upon the exercise of any Common Stock
Equivalents, in each case, outstanding immediately prior to such issue or sale multiplied by the fair market value of such Common Stock immediately prior to such issue or sale, plus (ii) the consideration received by the Company upon such issue or
sale or, as applicable, to be received by the Company upon the exercise of any Common Stock Equivalents, and (y) the denominator of which shall be the product of (i) the total number of shares of Common Stock and Common Stock issuable upon the
exercise of any Common Stock Equivalents, in each case, outstanding immediately after such issue or sale, multiplied by (ii) the fair market value of such Common Stock immediately prior to such issue or sale. 
  
 6.3. Option Grants. In the event that at any time,
the Company shall in any manner grant any rights to subscribe for or to purchase, or any options for the purchase of, Common Stock or any stock or securities convertible into or exchangeable for 

  

 7 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 
Common Stock, except for any Excluded Security (such rights or options being herein called “Options” and such convertible or exchangeable stock or
securities being herein called “Convertible Securities”), whether or not such Options or the right to convert or exchange any such Convertible Securities issuable upon the exercise of such Options are immediately exercisable, and the price
per share for which Common Stock is issuable upon the exercise of such Options or upon conversion or exchange of such Convertible Securities issuable upon the exercise of such Options (determined by dividing (i) the total amount, if any, received or
receivable by the Company as consideration for the granting of such Options, plus the minimum aggregate amount of additional consideration payable to the Company upon the exercise of all such Options, plus, in the case of any such Options which
relate to Convertible Securities, the minimum aggregate amount of additional consideration, if any, payable upon the issue or sale of such Convertible Securities and upon the conversion or exchange thereof, by (ii) the maximum total number of shares
of Common Stock issuable upon the exercise of such Options or upon the conversion or exchange of such Convertible Securities issuable upon the exercise of such Options) shall be less than the fair market value of such Common Stock, determined as of
the date of granting such Options, then the total number of shares of Common Stock issuable upon the exercise of such Options or upon conversion or exchange of the total amount of such Convertible Securities issuable upon the exercise of such
Options shall (as of the date of granting such Options) be deemed to be outstanding and to have been issued for such price per share. Except as otherwise provided in subsection 6.5, no further adjustment of the Exercise Price shall be made upon the
actual issue of such Common Stock or of such Convertible Securities upon exercise of such Options or upon the actual issue of such Common Stock upon conversion or exchange of such Convertible Securities. 
  
 6.4. Convertible Security Grants. In the event that
the Company shall in any manner issue or sell any Convertible Securities (other than pursuant to the exercise of Options to purchase such Convertible Securities covered by subsection 6.3 and other than Excluded Securities), whether or not the rights
to exchange or convert thereunder are immediately exercisable, and the price per share for which Common Stock is issuable upon such conversion or exchange (determined by dividing (i) the total amount received or receivable by the Company as
consideration for the issue or sale of such Convertible Securities, plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the conversion or exchange thereof, by (ii) the total maximum number of shares of
Common Stock issuable upon the conversion or exchange of all such Convertible Securities) shall be less than the fair market value of such Common Stock on the date of such issue or sale of such Convertible Securities, then the total maximum number
of shares of Common Stock issuable upon conversion or exchange of all such Convertible Securities shall (as of the date of the issue or sale of such Convertible Securities) be deemed to be outstanding and to have been issued for such price per
share, provided that, except as otherwise provided in subsection 6.5, no further adjustment of the Exercise Price shall be made upon the actual issue of such Common Stock upon conversion or exchange of such Convertible Securities. 
  

 8 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 6.5. Effect of Alteration to Option or Convertible Security Terms. In
connection with any change in, or the expiration or termination of, the purchase rights under any Option or the conversion or exchange rights under any Convertible Securities, the following provisions shall apply: 
  
 (a) If the exercise price provided for in any Option referred to in
subsection 6.3, the additional consideration, if any, payable upon the conversion or exchange of any Convertible Securities referred to in subsection 6.3 or 6.4, or the rate at which any Convertible Securities referred to in subsection 6.3 or 6.4
are convertible into or exchangeable for Common Stock shall change at any time (other than under or by reason of provisions designed to protect against dilution), then the Exercise Price in effect at the time of such change shall forthwith be
increased or decreased to the Exercise Price which would be in effect immediately after such change if (a) the adjustments which were made upon the issuance of such Options or Convertible Securities had been made upon the basis of (and taking into
account the total consideration received for) (i) the issuance at that time of the Common Stock, if any, delivered upon the exercise of any such Options or upon the conversion or exchange of any such Convertible Securities before such change, and
(ii) the issuance at that time of all such Options or Convertible Securities, with terms and provisions reflecting such change, which are still outstanding after such change, and (b) the Exercise Price as adjusted pursuant to clause (a) preceding
had been used as the basis for the adjustments required hereunder in connection with all other issues or sales of Common Stock, Options or Convertible Securities by the Company subsequent to the issuance of such Options or Convertible Securities.

  
 (b) On the partial or complete expiration of any Options or
termination of any right to convert or exchange Convertible Securities, the Exercise Price then in effect hereunder shall forthwith be increased or decreased to the Exercise Price which would be in effect at the time of such expiration or
termination if (a) the adjustments which were made upon the issuance of such Options or Convertible Securities had been made upon the basis of (and taking into account the total consideration received for) (i) the issuance at that time of the Common
Stock, if any, delivered upon the exercise of such Options or upon the conversion or exchange of such Convertible Securities before such expiration or termination, and (ii) the issuance at that time of only those such Options or Convertible
Securities which remain outstanding after such expiration or termination, and (b) the Exercise Price as adjusted pursuant to clause (a) preceding had been used as the basis for adjustments required hereunder in connection with all other issues or
sales of Common Stock, Options or Convertible Securities by the Company subsequent to the issuance of such Options or Convertible Securities. 
  
 (c) If the exercise price provided for in any Option referred to in subsection 6.3 or the rate at which any Convertible Securities referred to in
subsection 6.3 or 6.4 are convertible into or exchangeable for Common Stock shall be reduced at any time under or by reason or provisions with respect thereto designed to protect against dilution, and the event causing such reduction is one that did
not also require an adjustment in the Exercise Price under other provisions of this Section 6, then in case of the delivery of shares of Common Stock upon the exercise of any such Option or upon conversion or exchange of any such Convertible
Securities, the Exercise Price then in effect hereunder shall forthwith be adjusted to such amount as would have been obtained if such Option or Convertible Securities had never been issued and if the 

  

 9 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 
adjustments made upon the issuance of such Option or Convertible Securities had been made upon the basis of the issuance of (and taking into account the
total consideration received for) the shares of Common Stock delivered as aforesaid (provided that the fair market value of such Common Stock shall be the fair market value on the date of issue of such shares); provided that no such adjustment shall
be made unless the Exercise Price then in effect would be reduced thereby. 
  
 6.6. Stock Splits and Reverse Splits. In the event that the Company shall at any time subdivide its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately
prior to such subdivision shall be proportionately reduced and the number of Warrant Shares purchasable pursuant to this Warrant immediately prior to such subdivision shall be proportionately increased, and conversely, in the event that the
outstanding shares of Common Stock of the Company shall at any time be combined into a smaller number of shares, the Exercise Price in effect immediately prior to such combination shall be proportionately increased and the number of Warrant Shares
purchasable upon the exercise of this Warrant immediately prior to such combination shall be proportionately reduced. Except as provided in this subsection 6.6, no adjustment in the Exercise Price and no change in the number of Warrant Shares
purchasable shall be made under this Section 6 as a result of or by reason of any such subdivision or combination. 
  
 6.7. Determination of Consideration Received. For purposes of this Section 6, the amount of consideration received by the Company
in connection with the issuance or sale of Common Stock, Options or Convertible Securities shall be determined in accordance with the following: 
  
 (a) In the event that shares of Common Stock, Options or Convertible Securities shall be issued or sold for cash, the consideration received therefor
shall be deemed to be the amount payable to the Company therefor, without deduction therefrom of any expenses incurred or any underwriting commissions or concessions or discounts paid or allowed by the Company in connection therewith. 
  
 (b) In the event that any shares of Common Stock, Options or Convertible
Securities shall be issued or sold for a consideration other than cash, the amount of the consideration other than cash payable to the Company shall be deemed to be the fair value of such consideration as reasonably determined by the Board of
Directors of the Company, without deduction of any expenses incurred or any underwriting commissions or concessions or discounts paid or allowed by the Company in connection therewith. 
  
 (c) In the event that any shares of Common Stock, Options or Convertible Securities shall be issued in connection with any
merger in which the Company is the surviving corporation, the amount of consideration therefor shall be deemed to be the fair value as reasonably determined by the Board of Directors of the Company of such portion of the assets and business of the
non-surviving corporation as such Board shall determine to be attributable to such Common Stock, Options or Convertible Securities, as the case may be. 
  

 10 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 (d) In the event that any Common Stock, Options and/or Convertible Securities shall be issued in
connection with the issue and sale of Other Securities or property of the Company, together comprising one integral transaction in which no specific consideration is allocated to such Common Stock, Options or Convertible Securities by the parties
thereto, such Common Stock, Options and/or Convertible Securities shall be deemed to have been issued without consideration. 
  
 6.8. Record Date as Date of Issue or Sale. In the event that at any time the Company shall take a record of the holders of its
Common Stock for the purpose of entitling them (i) to receive a dividend or other distribution payable in Common Stock, Options or Convertible Securities, or (ii) to subscribe for or purchase Common Stock, Options or Convertible Securities, then
such record date shall be deemed to be the date of the issue or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such
right of subscription or purchase, as the case may be. 
  
 6.9. Treasury Stock. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company, and the disposition of any such shares (other than their
cancellation without reissuance) shall be considered an issue or sale of Common Stock for the purposes of this Section 6. 
  
 6.10. De Minimis Adjustments. Notwithstanding the foregoing in this Section 6, no adjustment of the Exercise Price shall be made in
an amount less than $0.000001 per share, but any such lesser adjustment shall be carried forward and shall be made at the time of and together with the next subsequent adjustment which together with any adjustments so carried forward shall amount to
$0.000001 per share or more. 
  
 6.11. Other
Events. If any event occurs that would adversely affect each Holder’s rights but is not expressly provided for by this Section 6 (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights
with equity features), then the Company’s Board of Directors will make an appropriate adjustment in the Exercise Price so as to protect each Holder’s rights; provided, however, that no such adjustment will increase the Exercise Price or
decrease the number of shares of Common Stock obtainable as otherwise determined pursuant to this Section 6.11. 
  
 6.12. No Change in Warrants Terms on Adjustment. Irrespective of any adjustments in the Exercise Price or the number of shares of
Common Stock (or any inclusion of Other Securities) issuable upon exercise, Warrants theretofore or thereafter issued may continue to express the same prices and number of shares as are stated in the similar Warrants issuable initially, or at some
subsequent time, pursuant to this Warrant, and the Exercise Price and such number of shares issuable upon exercise specified thereon shall be deemed to have been so adjusted. 
  

 11 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 6.13. Multiple Issuances. If additional shares of Common Stock, Convertible
Securities, Common Stock Equivalents, Other Securities or rights or options are issued or sold together with other stock or securities or other assets of the Company for a consideration which covers both, the consideration received shall be computed
as the portion of the consideration so received that may be reasonably determined in good faith by the Board of Directors to be allocable to such additional shares of Common Stock, Convertible Securities, Common Stock Equivalents, Other Securities
or rights or Options. 
  
 7. No Dilution or Impairment. The Company will
not, by amendment of its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or
performance of any of the terms of the Warrants, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holders
of the Warrants against dilution or other impairment. Without limiting the generality of the foregoing, the Company (a) will take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid
and nonassessable shares of stock on the exercise of all Warrants from time to time outstanding, (b) will not issue any capital stock of any class which is preferred as to dividends or as to the distribution of assets upon voluntary or involuntary
dissolution, liquidation or winding up, unless the rights of the holders thereof shall be limited to a fixed liquidation preference, which may included dividends that accrue at a fixed rate through the date of such dissolution, liquidation or
winding up and (c) will not transfer all or substantially all of its properties and assets to any other Person (corporate or otherwise), or consolidate with or merge into any other Person or permit any such Person to consolidate with or merge into
the Company (if the Company is not the surviving Person), unless such other Person shall expressly assume in writing and become bound by all the terms of the Warrants. 
  
 8. Certificate as to Adjustments. In each case of any adjustment or readjustment in the Exercise Price or in the number of shares of
Common Stock (or Other Securities) issuable on the exercise of the Warrants, the Company will promptly compute such adjustment or readjustment in accordance with the terms of the Warrants and prepare a certificate setting forth such adjustment or
readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including a statement of (a) the consideration received or receivable by the Company for any additional shares of Common Stock (or Other Securities)
issued or sold or deemed to have been issued or sold, (b) the number of shares of Common Stock (or Other Securities) outstanding or deemed to be outstanding, and (c) the Exercise Price and the number of shares of Common Stock to be received upon
exercise of this Warrant, in effect immediately prior to such issue or sale and as adjusted and readjusted as provided in this Warrant. The Company will forthwith mail a copy of each such certificate to each Holder of a Warrant, and will, on the
written request at any time of any Holder of a Warrant, furnish to such Holder a like certificate setting forth the Exercise Price at the time in effect and showing how it was calculated. 
  

 12 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 9. Notices of Record Date. etc. In the event of: 
  
 (a) any taking by the Company of a record of the Holders of any class of
securities for the purpose of determining the Holders thereof who are entitled to receive any dividend or other distribution or any right to subscribe for, purchase or otherwise acquire any shares of stock of any class or any Other Securities or
property, or to receive any other right, or 
  
 (b) any capital
reorganization of the Company, any reclassification or recapitalization of the capital stock of the Company or any transfer of all or substantially all the assets of the Company to or consolidation or merger of the Company with or into any other
Person, or 
  
 (c) any voluntary or involuntary dissolution,
liquidation or winding-up of the Company, 
  
 then and in each such event the
Company will mail or cause to be mailed to each Holder of a Warrant a notice specifying (i) the date on which any such record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such
dividend, distribution or right, (ii) the date on which any such reorganization, reclassification, recapitalization, transfer, consolidation, merger, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed, as of
which the holders of record of Common Stock (or Other Securities) shall be entitled to exchange their shares of Common Stock (or Other Securities) for securities or other property deliverable on such reorganization, reclassification,
recapitalization, transfer, consolidation, merger, dissolution, liquidation or winding-up, and (iii) the amount and character of any stock or Other Securities, or rights or options with respect thereto, proposed to be issued or granted, the date of
such proposed issue or grant and the Persons or class of Persons to whom such proposed issue or grant is to be offered or made. Such notice shall be mailed at least ten (10) business days prior to the date specified in such notice on which any such
action is to be taken pursuant to (a) above and five (5) business days prior to the date specified in such notice on which any such action is to be taken in any other case. 
  
 10. Certain Covenants. 
  
 10.1. Reservation of Stock, etc. Issuable on Exercise of Warrants. The Company will at all times reserve and keep available, solely
for issuance and delivery on the exercise of the Warrants, all shares of Common Stock (or Other Securities) from time to time issuable on the exercise of the Warrants. The Company will not increase or permit to be increased the par value per share
or stated capital of the shares of the Common Stock (or Other Securities) issuable on the exercise of the Warrants, and in the event that the exercise of the Warrants would require the payment by the Holder of consideration for the Common Stock (or
Other Securities) receivable upon such exercise of less than the par or stated value of such shares, the Company will promptly take such action as may be necessary to change the par or stated value of such shares to an amount less than or equal to
such consideration. 
  
 10.2. Regulatory
Requirements and Restrictions. In the event of any reasonable determination by the Holder of this Warrant that, by reason of any change in, or enactment, creation or imposition of, any federal or state law, statute, rule, regulation, 

  

 13 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 
guideline, order, court or administrative ruling, request or directive (whether or not having the force of law and whether or not failure to comply therewith
would be unlawful) (collectively, a “Regulatory Requirement”), the Holder of this Warrant is effectively restricted or prohibited from holding this Warrant or shares of Common Stock (or Other Securities) issuable upon exercise of
this Warrant, or otherwise realizing upon or receiving the benefits intended under this Warrant, the Company shall take such action as the Holder of this Warrant and the Company shall jointly agree in good faith to be reasonably necessary to permit
the Holder of this Warrant to comply with such Regulatory Requirement. The reasonable costs of taking such action, whether by the Company, the Holder of this Warrant or otherwise, shall be borne by the Holder. 
  
 10.3. Limitation on Certain Restrictions. The Company
will not, directly or indirectly, create or otherwise cause or suffer to exist or become effective any prohibition on the ability of the Company to perform and comply with its obligations under this Warrant. 
  
 11. Exchange of Warrants. On surrender for exchange of any Warrant, properly endorsed,
to the Company, the Company at its expense will issue and deliver to or on the order of the Holder thereof a new Warrant or Warrants of like tenor, in the name of such Holder or as such Holder (on payment by such Holder of any applicable transfer
taxes) may direct, calling in the aggregate on the face or faces thereof for the number of shares of Common Stock called for on the face or faces of the Warrant or Warrants so surrendered (as such number may be adjusted in accordance with the terms
hereof). No service charge will be imposed in connection with any transfer or exchange of any Warrant, but the Company or the Warrant Agent, as applicable, may require payment of a sum sufficient to cover any transfer tax or similar governmental
charge payable in connection therewith. 
  
 12. Replacement of Warrants. On
receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of any Warrant and, in the case of any such loss, theft or destruction of any Warrant, on delivery of an indemnity agreement or security
reasonably satisfactory in form and amount to the Company or, in the case of any such mutilation, on surrender and cancellation of such Warrant, the Company at the Holder’s expense will execute and deliver, in lieu thereof, a new Warrant of
like tenor. 
  
 13. Warrant Agent. The Company may elect to appoint an
agent (the “Warrant Agent”) having an office in the United States of America for the purpose of issuing Common Stock (or Other Securities) on the exercise of the Warrants pursuant to Section 2, exchanging Warrants pursuant to
Section 11, and replacing Warrants pursuant to Section 12. If the Company elects to appoint such a Warrant Agent, the Company shall notify the Holder of the name, address and other contact information for the Warrant Agent at least ten days prior to
the effective date of the appointment. Upon such appointment, any such issuance, exchange or replacement, as the case may be, shall be made at such office of and by the Warrant Agent. The Warrant Agent shall accept, in its own name for the account
of the Company or such successor Person as may be entitled thereto, all amounts otherwise payable to the Company or such successor, as the case may be, on exercise of this Warrant pursuant to this Section 13. The appointment of the Warrant 

  

 14 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 
Agent shall not relieve the Company of its obligations set forth in this Warrant. The Company may replace the Warrant Agent or terminate its services upon
not less than ten days prior notice to the Holder. 
  
 The Company
intends to select Wells Fargo Bank, N.A. as the Warrant Agent. So long as the appointment of Wells Fargo Bank, N.A. is effected prior to November 1, 2004, no notice of the actual appointment of Wells Fargo Bank, N.A. shall be required under this
Agreement. 
  
 14. Remedies. The Company stipulates that the remedies at
law of the Holder of this Warrant in the event of any default or threatened default by the Company in the performance of or compliance with any of the terms of this Warrant are not and will not be adequate, and that such terms may be specifically
enforced by a decree for the specific performance of any agreement contained herein or by an injunction against a violation of any of the terms hereof or otherwise. 
  
 15. Negotiability, etc. This Warrant is issued upon the following terms, to all of which each Holder consents and agrees by accepting
this Warrant: 
  
 (a) title to this Warrant may be transferred by
endorsement (by the Holder hereof executing the form of assignment at the end hereof) and delivery in the same manner as in the case of a negotiable instrument transferable by endorsement and delivery; and 
  
 (b) any Person in possession of this Warrant properly endorsed for transfer
to such Person (including endorsed in blank) is authorized to represent himself as absolute owner hereof and is empowered to transfer absolute title hereto by endorsement and delivery hereof to a bona fide purchaser hereof for value; each prior
taker or owner waives and renounces all of his equities or rights in this Warrant in favor of each such bona fide purchaser, and each such bona fide purchaser shall acquire absolute title hereto and to all rights represented hereby. Nothing in this
paragraph (b) shall create any liability on the part of the Company beyond any liability or responsibility it has under law. 
  
 16. Notices, etc. All notices and other communications from the Company to the Holder of this Warrant shall be sent by electronic transmission, first class mail
postage prepaid, by hand delivery or by overnight mail or courier service, at such address as may have been furnished to the Company in writing by such Holder or, until any such Holder furnishes to the Company an address, then to, and at the address
of, the last Holder of this Warrant who has so furnished an address to the Company. 
  
 17. Miscellaneous. This Warrant shall be construed and enforced in accordance with and governed by the laws of the State of Delaware, without regard to the principles of conflicts of laws. The headings in this Warrant are for
purposes of reference only, and shall not limit or otherwise affect any of the terms hereof. This Warrant is being executed as an instrument under seal. The invalidity or unenforceability of any provision hereof shall in no way affect the validity
or enforceability of any other provision. 
  

 15 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 18. Exercise Period. This Warrant may be exercised from time to time during the period (the “Exercise
Period”) commencing on the Issue Date and expiring on August 23, 2011. Notwithstanding the foregoing, this Warrant shall automatically be deemed to be exercised in full pursuant to the provisions of Section 2.4 hereof, without any further
action on behalf of the Holder, immediately prior to the time this Warrant would otherwise expire pursuant to the preceding sentence. 
  
 19. Holder Not Deemed Stockholder. Until the exercise of this Warrant, the Holder shall not have or exercise any rights by virtue hereof as a stockholder of the
Company. 
  
 20. CUSIP and CINS Numbers. The Company in issuing the
Warrants may use “CUSIP” and “CINS” numbers. 
  
 21.
Legend. 
  
 Each Warrant certificate evidencing the
Warrants (and all Warrant certificates issued in exchange therefor or substitution thereof) shall bear a legend in substantially the following form: 
  
 “THIS WARRANT AND THE WARRANT SHARES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN ISSUED PURSUANT TO THE DEBTORS’ AND OFFICIAL COMMITTEE OF UNSECURED
CREDITORS’ THIRD AMENDED REVISED JOINT PLAN OF REORGANIZATION OF FLEMING COMPANIES, INC. AND ITS FILING SUBSIDIARIES UNDER CHAPTER 11 OF THE UNITED STATES BANKRUPTCY CODE CONFIRMED IN THE BANKRUPTCY CASES OF FLEMING COMPANIES, INC. AND CERTAIN
OF ITS SUBSIDIARIES BY THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE, CASE NO. 03-10945 (MFW) JOINTLY ADMINISTERED. ANY WARRANT SHARES ISSUABLE UPON EXERCISE HEREOF AND ANY INTEREST THEREIN IS EXEMPT FROM REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND ANY STATE AND LOCAL SECURITIES LAWS AND IS FREELY TRANSFERABLE PURSUANT TO SECTION 1145(A) OF THE BANKRUPTCY CODE.” 
  
 “NO WARRANTS AND NO WARRANT SHARES HELD BY AN UNDERWRITER OR AN
AFFILIATE OF THE COMPANY MAY BE SOLD, EXCHANGED OR OTHERWISE TRANSFERRED IN VIOLATION OF THE SECURITIES ACT OR STATE SECURITIES LAWS. ACCORDINGLY, THE COMPANY RECOMMEND THAT POTENTIAL RECIPIENTS OF WARRANTS AND WARRANT SHARES CONSULT THEIR OWN
COUNSEL CONCERNING WHETHER THEY MAY FREELY TRADE SUCH SECURITIES.” 
  

 16 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 The legend set forth above shall be removed by the Company from any certificate
evidencing the Warrants and the Warrant Shares upon delivery to the Company of an opinion of counsel, reasonable satisfactory to the Company, that (a) the Warrants and the Warrant Shares are not held by an underwriter or affiliate of the Company or
(b) the Warrants and the Warrant Shares are held by an underwriter or affiliate of the Company and that such Warrants and Warrant Shares are being transferred pursuant to a registration statement under the Securities Act. 
  
 22. Amendment. This Warrant may be amended by the parties hereto without the consent
of any Holder for the purpose of curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein or making any other provisions with respect to matters or questions arising under this Warrant as the Company
and the Warrant Agent (as applicable) may deem necessary or desirable. Except as otherwise provided herein, the provisions of the Warrants may be amended and the Company may take any action herein prohibited, or omit to perform any act herein
required to be performed by it, only if the Company has obtained the written consent of the Majority Warrantholders (excluding the vote of any Warrants held by the Company or any parent, subsidiary or sister company) and provided that all Warrants
issued pursuant to the Agreement are equally treated. 
  
 23. Expenses. The
preparation, issuance and delivery of the new Warrant certificates shall be at the Company’s expense (other than transfer taxes). The Company shall not be required, however, to pay any tax or other charge imposed in connection with any transfer
of any Warrants, including, but not limited to, any transfer involved in the exchange of any Warrant certificates, and in such case the Company shall not be required to issue or deliver any Warrant certificates until such tax or other charge has
been paid or it has been established to the satisfaction of the Company that no such tax or other charge is due. If such tax or other charge is due, the Company or Warrant Agent (if applicable), shall have no duty or obligation or any other similar
provision of this Warrant Agreement unless and until it is satisfied that all such taxes and/or governmental charges have been paid in full. 
  
 24. Consent to Jurisdiction. Notwithstanding anything to the contrary contained in Section 17 hereof, (a) the parties hereby expressly acknowledge and agree that,
to the extent permitted by applicable law, the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) shall have exclusive jurisdiction to hear and determine any and all disputes concerning the
distribution of Warrants hereunder, and (b) if appointed, the Warrant Agent will consent to the jurisdiction of the Bankruptcy Court with respect to any such disputes and waives any argument of lack of such jurisdiction. 
  
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 17 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 IN WITNESS WHEREOF, the Company has executed this Warrant under seal as of the date first written
above. 
  

			
	CORE-MARK HOLDING COMPANY, INC.
		
	By:	 	  

	Name:	 	 
	Title:	 	 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 EXHIBIT A 
 TO 
 WARRANT AGREEMENT 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 FORM OF ELECTION FOR CASHLESS EXERCISE PURSUANT TO SECTION 2.4 
  
 The undersigned hereby irrevocably elects to purchase
             shares of Common Stock of Core-Mark Holding Company, Inc. on the terms and conditions specified in the within Warrant Certificate and tenders payment of the exercise
price for these shares by electing pursuant to Section 2.4 of the within Warrant Certificate to surrender the right to purchase              shares of Common Stock;; and directs that
the shares of Common Stock deliverable upon the exercise of such Warrants be registered or placed in the name and at the address specified below and delivered thereto. 
  
 Date:                     ,
     
  

	
	  

	(Signature of Owner)1
	
	  

	(Street Address)
	
	  

	(City)    (State)    (Zip Code)
	
	Signature Guaranteed by:
	
	  

  
 Securities and/or check to be
issued to: 
  
 Please insert social security or identifying number: 

 
 Name: 
  
 Street Address: 
  
 City, State and Zip Code: 

	1	The signature must correspond with the name as written upon the face of the within Warrant Certificate in every particular, without alteration or enlargement or any
change whatsoever, and must be guaranteed by a national bank or trust company or by a member firm of any national securities exchange. 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 Any unexercised Warrants evidenced by the within Warrant certificate to be issued to: 
  
 Please insert social security or identifying number: 
  
 Name: 
  
 Street Address: 
  
 City, State and Zip Code: 
  

 21 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 FORM OF ELECTION TO PURCHASE WARRANT SHARES FOR CASH 
 (to be executed only upon exercise of Warrants) 
  
 The undersigned hereby irrevocably elects to purchase              shares of Common
Stock of Core-Mark Holding Company, Inc. on the terms and conditions specified in the within Warrant Certificate and tenders herewith payment of $            , the Exercise Price for
             shares; and directs that the shares of Common Stock deliverable upon the exercise of such Warrants be registered or placed in the name and at the address specified below
and delivered thereto. 
  
 Date:
                    ,      
  

	
	  

	(Signature of Owner)2
	
	  

	(Street Address)
	
	  

	(City)    (State)    (Zip Code)
	
	Signature Guaranteed by:
	
	  

  
 Securities and/or check to be
issued to: 
  
 Please insert social security or identifying number: 

 
 Name: 
  
 Street Address: 
  
 City, State and Zip Code: 

	2	The signature must correspond with the name as written upon the face of the within Warrant
Certificate in every particular, without alteration or enlargement or any change whatsoever, and must be guaranteed by a national bank or trust company or by a member firm of any national securities exchange. 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 Any unexercised Warrants evidenced by the within Warrant certificate to be issued to: 
  
 Please insert social security or identifying number: 
  
 Name: 
  
 Street Address: 
  
 City, State and Zip Code: 
  

 23 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

 FORM OF ASSIGNMENT 
  
 (To be signed only upon transfer of Warrant) 
  
 For value received, the undersigned hereby sells, assigns and transfers unto
             the right represented by the within Warrant to purchase              shares of Common Stock of
Core-Mark Holding Company, Inc. to which the within Warrant relates, and appoints              Attorney to transfer such right on the books of Core-Mark Holding Company, Inc. with
full power of substitution in the premises. 
  
 Alternative
1: The undersigned is not currently an affiliate of the Company or an underwriter engaged in the distribution of such Warrant as those terms are defined in the rules of the Securities and Exchange Commission. 
  
 Or 
  
 Alternative 2: If the undersigned is an affiliate or an underwriter, (a) the undersigned has sold the securities
represented by the within Warrant pursuant to a registration statement filed and made effective in accordance with the Securities Act and in a manner described under the caption “Plan of Distribution” in the prospectus included in such
registration statement and that such sale complies with all applicable securities laws applicable to the undersigned, including without limitation, the prospectus delivery requirements, or (b) only in the case of an affiliate, has transferred such
securities pursuant to an exemption from registration under the Securities Act and provided reasonable evidence of such exemption. 
  
 The Warrant being transferred hereby is one of the Warrants issued by Core-Mark Holding Company, Inc. as of August 23, 2004 to purchase an aggregate of
             shares of Common Stock. 
  
 Date:                     ,      
  

	
	  

	(Signature of Owner)3
	
	  

	(Street Address)

	3	The signature must correspond with the name as written upon the face of the within Warrant
certificate in every particular, without alteration or enlargement or any change whatsoever, and must be guaranteed by a national bank or trust company or by a member firm of any national securities exchange. 

 [Common Stock Purchase Warrant
WS-[            ]] 
 [                        ] 
  

	
	  

	(City)    (State)    (Zip Code)
	
	Signature Guaranteed by:
	
	  

 Securities to be issued to: 
  
 Please insert social security or identifying number: 
  
 Name: 
  
 Street Address: 
  
 City, State and Zip Code: 
  

 252004 Long-Term Incentive Plan

 EXHIBIT 10.1 
  
 CORE-MARK HOLDING COMPANY, INC. 
 2004 LONG-TERM INCENTIVE PLAN 
  
 1.
Purpose. 
  
 This plan shall be known as the Core-Mark
Long-Term Incentive Plan (the “Plan”). The purpose of the Plan shall be to promote the long-term growth and profitability of Core-Mark Holding Company, Inc., a Delaware corporation (the “Company”), and its
Subsidiaries by (i) providing certain directors, officers and employees of, and certain other individuals who perform services for, or to whom an offer of employment has been extended by, the Company and its Subsidiaries with incentives to maximize
stockholder value and otherwise contribute to the success of the Company and (ii) enabling the Company to attract, retain and reward the best available persons for positions of responsibility. Grants of Incentive Stock Options, Non-qualified Stock
Options, restricted stock shares, restricted stock units, stock appreciation rights and performance awards, either alone or in tandem or in any combination of the foregoing, may be made under the Plan. 
  
 2. Definitions. 
  
 (a) “Awards” means grants of Incentive Stock Options, Non-qualified Stock Options, restricted stock shares,
restricted stock units, SARs, performance awards or any combination of the foregoing. 
  
 (b) “Board” means the board of directors of the Company. 
  
 (c) “Business Combination” means a reorganization, merger or consolidation or sale or other disposition of all or substantially all of
the, assets of the Company (a “Business Combination”). 
  
 (d) “Cause,” unless otherwise provided in any Grant Agreement, means the occurrence of one or more of the following events: 
  
 (i) Conviction of, or agreement to a plea of nolo contendere to, a felony; or 
  
 (ii) Willful misconduct or gross negligence that has caused demonstrable and serious injury to the Company or a Subsidiary,
monetary or otherwise; or 
  
 (iii) Willful insubordination or
failure to follow a reasonable, lawful directive of the Board or the Participant’s direct or indirect supervisor made in good faith; or 
  
 (iv) Breach of duty of loyalty to the Company or a Subsidiary or other act of fraud or dishonesty with respect to the Company or a Subsidiary; or

 (v) Material violation of the Company’s written code of conduct; or 
  
 (vi) Any willful breach of any written policy or any confidential or
proprietary information, non-compete or non-solicitation covenant for the benefit of the Company, its subsidiaries or any of its affiliates that has caused demonstrable and serious injury to the Company. 
  
 (e) “Change in Control” means the occurrence after the
Commencement Date of one of the following events: 
  
 (i) Any
“person” or “group” as those terms are used in Sections 13(d) and 14(d) of the Exchange Act or any successors thereto is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act or any
successor thereto), directly or indirectly, of securities of the Company representing 40% or more of the combined voting power of the Company’s then outstanding securities; or 
  
 (ii) The Incumbent Directors cease for any reason, including without limitation, as a result of a tender offer, proxy
contest, merger or similar transaction, to constitute at least a majority of the Board; provided that, any person who becomes a director of the Company subsequent to the Commencement Date shall be considered an Incumbent Director if such
person’s election or nomination for election was approved by a vote of at least two-thirds (2/3) of the Incumbent Directors then in office; but provided further that, any such person whose initial assumption of office on the Board is in
connection with an actual or threatened election contest relating to the election of members of the Board or other actual or threatened solicitation of proxies or consents by or on behalf of a “person” (as defined in Sections 13(d) and
14(d) of the Exchange Act) other than the Board, including by reason of agreement intended to avoid or settle any such actual or threatened contest or solicitation, shall not become an Incumbent Director; or 
  
 (iii) The consummation of any Business Combination, in each case, unless,
following such Business Combination, all or substantially all of the individuals and entities who were the beneficial owners of outstanding voting securities of the Company immediately prior to such Business Combination beneficially own, directly or
indirectly, more than 50% of the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the company resulting from such Business Combination (including, without
limitation, a company which, as a result of such transaction, owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the outstanding voting securities of the Company; or 
  
 (iv) The stockholders of the Company approve any plan or proposal for the complete liquidation or dissolution of the Company; or 
  

 2 

 (v) The stockholders of the Company approve the sale or other disposition of all or substantially all of
the assets of the Company and such transaction is consummated; or 
  
 (vi) The stockholders of the Company approve a going private transaction which will result in the Shares no longer being publicly traded and such transaction is consummated. 
  
 (f) “Code” means the Internal Revenue Code of 1986, as amended. 
  
 (g) “Commencement Date” means the effective date of the plan
of reorganization of the Company. 
  
 (h)
“Committee” means the Compensation Committee of the Board or such other committee which shall consist solely of two or more members of the Board, each of whom is an “outside director” within the meaning of Treasury
Regulation § 1.162-27(e)(3); provided that, if for any reason the Committee shall not have been appointed by the Board to administer the Plan, all authority and duties of the Committee under the Plan shall be vested in and exercised by the
Board, and the term “Committee” shall be deemed to mean the Board for all purposes herein. 
  
 (i) “Common Stock” means the Common Stock, par value $0.01 per share, of the Company, and any other shares into which such stock may be
changed by reason of a recapitalization, reorganization, merger, consolidation or any other change in the corporate structure or capital stock of the Company. 
  

(j) “Disability,” unless otherwise defined in a Participant’s Grant Agreement, means a disability that would entitle an eligible
Participant to payment of monthly disability payments under any Company long-term disability plan or as otherwise determined by the Committee. 
  
 (k) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
  
 (l) “Fair Market Value” of a share of Common Stock of the Company means, as of the date in question, and
except as otherwise provided in any Grant Agreement, the officially-quoted closing selling price of the stock (or if no selling price is quoted, the bid price) on the principal securities exchange on which the Common Stock is then listed for trading
(including for this purpose the Nasdaq National Market) for the applicable trading day or, if the Common Stock is not then listed or quoted on any such market, the Fair Market Value shall be the fair value of the Common Stock determined in good
faith by the Board and, in the case of an Incentive Stock Option, in accordance with Section 422 of the Code; provided, however, that when shares received upon exercise of an option are immediately sold in the open market, the net sale price
received maybe used to determine the Fair Market Value of any shares used to pay the exercise price or applicable withholding taxes and to compute the withholding taxes. 
  

 3 

 (m) “Family Member” has the meaning given to such term in General Instructions A.1(a)(5)
to Form S-8 under the Securities Act of 1933, as amended, and any successor thereto. 
  
 (n) “Grant Agreement” means the written agreement that each Participant to whom an Award is made under the Plan is required to enter into with the Company containing the terms and conditions of such
grant as are determined by the Committee and consistent with the Plan. 
  
 (o) “Incentive Stock Option” means an option conforming to the requirements of Section 422 of the Code and any successor thereto. 
  
 (p) “Incumbent Directors” means the persons who on the Commencement Date constitute the Board and any other persons who subsequently
become “Incumbent Directors” pursuant to the terms of Section 2(e)(ii). 
  
 (q) “Non-qualified Stock Option” means any stock option other than an Incentive Stock Option. 
  
 (r) “Option” means any Incentive Stock Option or Non-qualified Stock Option issued hereunder. 
  
 (s) “Other Company Securities” mean securities of the
Company other than Common Stock, which may include, without limitation, unbundled stock units or components thereof, debentures, preferred stock, warrants and securities convertible into or exchangeable for Common Stock or other property.

  
 (t) “Participant” means any director, officer
(including a non-employee officer) or employee of, or other individual performing services for, or to whom an offer of employment has been extended by, the Company or any Subsidiary who has been selected by the Committee to participate in the Plan
(including a Participant located outside the United States). 
  
 (u) “Retirement” means retirement as defined under the Company’s primary pension plan or retirement program or termination of one’s employment or retirement with the approval of the Committee. 
  
 (v) “SARs” means stock appreciation rights. 
  
 (w) “Shares” means the shares of Common Stock that may be
issued pursuant to the Plan, including, without limitation, shares of Common Stock issuable, as restricted stock shares, upon the exercise of Incentive Stock Options and Non-qualified Stock Options, upon the conversion of restricted stock units or
otherwise in connection with an Award granted hereunder. 
  
 (x)
“Subsidiary” means a corporation or other entity of which outstanding shares or ownership interests representing 50% or more of the combined 

  

 4 

 
voting power of such corporation or other entity entitled to elect the management thereof, or such lesser percentage as may be approved by the Committee, are
owned directly or indirectly by the Company. 
  
 3. Administration.

  
 The Plan shall be administered by the Committee, provided
that the Board may, in its discretion, at any time and from time to time, resolve to administer the Plan directly, in which case the term “Committee” shall be deemed to mean the Board for all purposes herein. Subject to the provisions of
the Plan, the Committee shall be authorized to (i) select persons to participate in the Plan, (ii) determine the form and substance of grants made under the Plan to each Participant, and the conditions and restrictions, if any, subject to which such
grants will be made, (iii) determine the form and substance of the Grant Agreements reflecting the terms and conditions of each grant made under the Plan, (iv) certify that the conditions and restrictions applicable to any grant have been met, (v)
modify the terms of grants made under the Plan, (vi) interpret the Plan and Grant Agreements entered into under the Plan, (vii) determine the duration and purposes for leaves of absence which may be granted to a Participant on an individual basis
without constituting a termination of employment or services for purposes of the Plan, (viii) make any adjustments necessary or desirable in connection with grants made under the Plan to eligible Participants located outside the United States, (ix)
adopt, amend, or rescind rules and regulations for the administration of the Plan, including, but not limited to, correcting any defect or supplying any omission, or reconciling any inconsistency in the Plan or in any Grant Agreement, in the manner
and to the extent it shall deem necessary or advisable, including so that the Plan and the operation of the Plan complies with Rule 16b-3 under the Exchange Act, the Code to the extent applicable and other applicable law and make such other
determinations for carrying out the Plan as it may deem appropriate, and (x) exercise such powers and perform such acts as are deemed necessary or advisable to promote the best interests of the Company with respect to the Plan. Decisions of the
Committee on all matters relating to the Plan, any Award granted under the Plan and any Grant Agreement shall be in the Committee’s sole discretion and shall be conclusive and binding on the Company, all Participants and all other parties. The
validity, construction, and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with applicable federal and state laws and rules and regulations promulgated pursuant thereto. No member of the
Committee and no officer of the Company shall be liable for any action taken or omitted to be taken by such person, by any other member of the Committee or by any officer of the Company in connection with the performance of duties under the Plan,
except for such person’s own willful misconduct or as expressly provided by statute, 
  
 The expenses of the Plan shall be borne by the Company. The Plan shall not be required to establish any special or separate fund or make any other segregation of assets to assume the payment of any Award under the
Plan, and rights to the payment of such Awards shall be no greater than the rights of the Company’s general creditors. 
  

 5 

 4. Shares Available for the Plan. 
  
 Subject to adjustments as provided in Section 15, an aggregate of 1,314,444 Shares may be issued pursuant to the
Plan. Such Shares may be in whole or in part authorized and unissued or held by the Company as treasury shares. If any grant under the Plan expires or terminates unexercised, becomes unexercisable or is forfeited as to any Shares, or is tendered or
withheld as to any Shares in payment of the exercise price of the grant or the taxes payable with respect to the exercise, then such unpurchased, forfeited, tendered or withheld Shares shall thereafter be available for further grants under the Plan.

  
 Without limiting the generality of the foregoing provisions of
this Section 4 or the generality of the provisions of Sections 3, 6, 7 or 15 or any other section of this Plan, the Committee may, at any time or from time to time, and on such terms and conditions (that are
consistent with and not in contravention of the other provisions of this Plan) as the Committee may determine, enter into Grant Agreements (or take other actions with respect to the Awards) for new Awards containing terms (including, without
limitation, exercise prices) more (or less) favorable than the then-outstanding Awards. 
  
 5. Participation. 
  
 Participation in the Plan
shall be limited to Participants. Nothing in the Plan or in any Grant Agreement shall confer any right on a Participant to continue in the employ or service of the Company or any Subsidiary as a director, officer or employee of or in the performance
of services for the Company or shall interfere in any way with the right of the Company to terminate the employment or performance of services or to reduce the compensation or responsibilities of a Participant at any time. By accepting any Award
under the Plan, each Participant and each person claiming under or through him or her shall be conclusively deemed to have indicated his or her acceptance and ratification of, and consent to, any action taken under the Plan by the Company, the Board
or the Committee. 
  
 Awards may be granted to such persons and
for such number of Shares as the Committee shall determine, subject to the limitations contained herein (such individuals to whom grants are made being sometimes herein called “optionees” or “grantees,” as the case may be).
Determinations made by the Committee under the Plan, with respect to Awards and otherwise, need not be uniform and may be made selectively among eligible individuals under the Plan, whether or not such individuals are similarly situated. A grant of
any type made hereunder in any one year to an eligible Participant shall neither guarantee nor preclude a further grant of that or any other type to such Participant in that year or subsequent years. 
  
 6. Incentive and Non-qualified Options. 
  
 The Committee may from time to time grant to eligible Participants Incentive
Stock Options, Non-qualified Stock Options or any combination thereof 

 
(including Options in combination with SARs); provided that, the Committee may grant Incentive Stock Options only to eligible employees of the Company or its
Subsidiaries (as defined for this purpose in Section 424(f) of the Code or any successor thereto). In any one calendar year, the Committee shall not grant to any one Participant Options and SARs for a number of Shares in excess of 20% of the total
number of Shares authorized under the Plan pursuant to Section 4. The Options granted under the Plan shall be evidenced by a Grant Agreement and shall take such form as the Committee shall determine, subject to the terms and conditions of the
Plan. 
  
 It is the Company’s intent that Non-qualified Stock
Options granted under the Plan not be classified as Incentive Stock Options, that Incentive Stock Options be consistent with and contain or be deemed to contain all provisions required under Section 422 of the Code and any successor thereto, and
that any ambiguities in construction be interpreted in order to effectuate such intent. If an Incentive Stock Option granted under the Plan does not qualify as such for any reason, then to the extent of such non-qualification, the stock option
represented thereby shall be regarded as a Non-qualified Stock Option duly granted under the Plan; provided that such stock option otherwise meets the Plan’s requirements for Non-qualified Stock Options. 
  
 (a) Price. The price per Share deliverable upon the exercise of each
Option (the “exercise price”) shall be established by the Committee, except that in the case of the grant of any Incentive Stock Option, the exercise price may not be less than 100% of the Fair Market Value of a share of Common
Stock as of the date of grant of the Option, and in the case of the grant of any Incentive Stock Option to an employee who, at the time of the grant, owns more than 10% of the total combined voting power of all classes of stock of the Company or any
of its Subsidiaries, the exercise price may not be less than 110% of the Fair Market Value of a share of Common Stock as of the date of grant of the Option, in each case unless otherwise permitted by Section 422 of the Code or any successor thereto.

  
 (b) Payment. Options may be exercised, in whole or in
part, upon payment of the exercise price of the Shares to be acquired. Unless otherwise determined by the Committee, payment shall be made (i) in cash (including check, bank draft, money order or wire transfer of immediately available funds), (ii)
by delivery of outstanding shares of Common Stock with a Fair Market Value on the date of exercise equal to the aggregate exercise price payable with respect to the Options’ exercise, (iii) by means of any cashless exercise procedures approved
by the Committee and as may be in effect on the date of exercise or (iv) by any combination of the foregoing, and if the Committee so determines, any shares used as payment of the exercise price must have been owned by the Participant for at least
six months prior to the date of exercise. 
  
 In the event a
grantee is permitted to, and elects to pay the exercise price payable with respect to an Option pursuant to Section 6(b)(ii) above, (A) only a whole number of share(s) of Common Stock (and not fractional shares of Common Stock) may be
tendered in payment, (B) such grantee must present evidence acceptable to the Company that he or she has owned any such shares of Common Stock tendered in 

  

 7 

 
payment of the exercise price (and that such tendered shares of Common Stock have not been subject to any substantial risk of forfeiture) for at least six
months prior to the date of exercise or such longer period as determined from time to time by the Committee, and (C) Common Stock must be delivered to the Company. Delivery for this purpose may, at the election of the grantee, be made either by (A)
physical delivery of the certificate(s) for all such shares of Common Stock tendered in payment of the exercise price, accompanied by duly executed instruments of transfer in a form acceptable to the Company, or (B) direction to the grantee’s
broker to transfer, by book entry, such shares of Common Stock from a brokerage account of the grantee to a brokerage account specified by the Company. When payment of the exercise price is made by delivery of Common Stock, the difference, if any,
between the aggregate exercise price payable with respect to the Option being exercised and the Fair Market Value of the shares of Common Stock tendered in payment (plus any applicable taxes) shall be paid in cash. No grantee may tender shares of
Common Stock having a Fair Market Value exceeding the aggregate exercise price payable with respect to the Option being exercised (plus any applicable taxes). 
  

In the event a grantee elects to pay the exercise price payable with respect to an Option pursuant to Section 6(b)(iii) above, (A) only a whole
number of Share(s) (and not fractional Shares) may be withheld in payment and (B) if applicable, such grantee must present evidence acceptable to the Company that he or she has owned a number of shares of Common Stock at least equal to the number of
Shares to be withheld in payment of the exercise price (and that such owned shares of Common Stock have not been subject to any substantial risk of forfeiture) for at least six months prior to the date of exercise. When payment of the exercise price
is made by withholding of Shares, the difference, if any, between the aggregate exercise price payable with respect to the Option being exercised and the Fair Market Value of the Shares withheld in payment (plus any applicable taxes) shall be paid
in cash. No grantee may authorize the withholding of Shares having a Fair Market Value exceeding the aggregate exercise price payable with respect to the Option being exercised (plus any applicable taxes). Any withheld Shares shall no longer be
issuable under such Option (except pursuant to any Reload Option (as defined below) with respect to any such withheld Shares). 
  
 (c) Terms of Options. The term during which each Option may be exercised shall be determined by the Committee, but if required by the Code, no
Option shall be exercisable in whole or in part more than ten years from the date it is granted, and no Incentive Stock Option granted to an employee who at the time of the grant owns more than 10% of the total combined voting power of all classes
of stock of the Company or any of its Subsidiaries shall be exercisable more than five years from the date it is granted. All rights to purchase Shares pursuant to an Option shall, unless sooner terminated, expire on the date designated by the
Committee. The Committee shall determine the date on which each Option shall become exercisable and may provide that an Option shall become exercisable in installments. The Shares constituting each installment may be purchased in whole or in part at
any time after such installment becomes exercisable, subject to such minimum exercise requirements as may be 

  

 8 

 
designated by the Committee. Prior to the exercise of an Option and delivery of the Shares represented thereby, the optionee shall have no rights as a
stockholder with respect to any Shares covered by such outstanding Option (including any dividend or voting rights). 
  
 (d) Limitations on Grants. If required by the Code, the aggregate Fair Market Value (determined as of the grant date) of Shares for which an
Incentive Stock Option is exercisable for the first time during any calendar year under all equity incentive plans of the Company and its Subsidiaries (as defined in Section 422 of the Code or any successor thereto) may not exceed $100,000.

  
 (e) Vesting; Termination; Forfeiture of Options and
SARs. 
  
 (i) Death or Disability. Except as
Otherwise provided in any Grant Agreement, if a Participant ceases to be a director, officer or employee of, or to perform other services for, the Company or any Subsidiary due to death or Disability, all of the Participant’s Options and SARs
that were exercisable on the date of such Participant’s death or Disability shall remain exercisable for, a period of one year from the date of such death or Disability, but in no event after the expiration date of the Options or SARs.
Notwithstanding the foregoing, if the Disability giving rise to the termination of employment is not a “permanent and total disability” within the meaning of Section 22(e)(3) of the Code or any successor thereto, Incentive Stock Options
not exercised by such Participant within three months after the date of termination of employment will cease to qualify as Incentive Stock Options and will be treated as Non-qualified Stock Options under the Plan if required to be so treated under
the Code. 
  
 (ii) Retirement. Except as otherwise
provided in any Grant Agreement, if a Participant ceases to be a director, officer or employee of, or to perform other services for, the Company and any Subsidiary upon the occurrence of his or her Retirement, (A) all of the Participant’s
Options and SARs that were exercisable on the date of Retirement shall remain exercisable for, and shall otherwise terminate at the end of, a period of 90 days after the date of Retirement, but in no event after the expiration date of the Options or
SARs, and (B) all of the Participant’s Options and SARs that were not exercisable on the date of Retirement shall be forfeited immediately upon such Retirement; provided, however, that such Options and SARs may become fully vested and
exercisable in the discretion of the Committee. Notwithstanding the foregoing, Incentive Stock Options not exercised by such Participant within three months after Retirement will cease to qualify as Incentive Stock Options and will be treated as
Non-qualified Stock Options under the Plan if required to be so treated under the Code. 
  
 (iii) Discharge for Cause. Except as otherwise provided in any Grant Agreement and notwithstanding Section 6(e)(i) above, if a Participant ceases to be a director, officer or employee of, or to otherwise
perform services for, the Company or a Subsidiary due to Cause, or if a Participant does not become a director, officer or employee of or does not begin performing other services for the Company or a Subsidiary for any reason, all of the
Participant’s Options and SARs shall expire and be forfeited immediately, whether or not then exercisable, upon such cessation or non-commencement. 
  

 9 

 (iv) Other Termination. Except as otherwise provided in any Grant Agreement, if a Participant
ceases to be a director, officer or employee of, or to otherwise perform services for, the Company or a Subsidiary for any reason other than Death, Disability, Retirement or Cause (which are covered by Sections 6(e)(i), (ii) and (iii) above), (A)
all of the Participant’s Options and SARs that were exercisable on the date of such cessation shall remain exercisable for, and shall otherwise terminate and thereafter be forfeited at the end of, a period of 90 days after the date of such
cessation, but in no event after the expiration date of such Options or SARs, and (B) all of the Participant’s Options and SARs that were not fully vested and exercisable on the date of such cessation shall be forfeited immediately upon such
cessation. 
  
 (v) Change in Control. Except as otherwise
provided in any Grant Agreement and notwithstanding Section 6(e)(iv) above, if a Change in Control occurs, all of the Participants’ Options and SARs shall become fully vested and exercisable upon such Change in Control. In addition, the
Committee shall have the authority to grant Options, SARs and other Awards that: (i) do not fully vest and become exercisable automatically upon a Change in Control, (ii) vest depending on whether or not the grantee is terminated after or upon a
Change in Control and (iii) provide for accelerated vesting after a Change in Control if certain conditions are met or certain events take place. The Committee shall also have the authority to modify the definition of “Change in Control”
for purposes of any Grant Agreement. 
  
 (vi) Forfeiture.
Except as otherwise provided in any Grant Agreement, if a Participant exercises any of his or her options or SARs and, within one year thereafter, is terminated from the Company or a Subsidiary for any of the reasons specified in the definition of
“Cause” set forth in Section 2(d)(i), (ii), (iv) or (v) hereof (or as such clauses may be amended in any Grant Agreement), then the Participant may, in the discretion of the Committee, be required to pay the Company (x) in the case of
Options, the gain represented by the difference between the aggregate selling price of the Shares acquired upon the Options’ exercise (or, if the Shares were not then sold, their aggregate Fair Market Value on the date of exercise) and the
aggregate exercise price of the Options exercised (the “Option Gain”), without regard to any subsequent increase or decrease in the Fair Market Value of the Common Stock, and (y) in the case of SARs, the amount of the distribution made to
the Participant upon the exercise of such SARs (the “SARs Distribution”). In addition, the Company may, in its discretion, deduct from any payment of any kind (including salary or bonus) otherwise due to any such Participant an amount
equal to such Option Gain or SARs Distribution. 
  
 (vii)
Grant of Reload Options. The Committee may provide (either at the time of grant or exercise of an Option), in its discretion, for the grant to a grantee who exercises all or any portion of an Option (“Exercised Options”) and who
pays all or part of such exercise price with shares of Common Stock, of an additional Option (a “Reload Option”) for a number of shares of Common Stock equal to the sum 

  

 10 

 
(the “Reload Number”) of the number of shares of Common Stock tendered or withheld in payment of such exercise price for the Exercised Options
plus, if so provided by the Committee, the number of shares of Common Stock, if any, tendered or withheld by the grantee or withheld by the Company in connection with the exercise of the Exercised Options to satisfy any federal, state or local tax
withholding requirements. The terms of each Reload Option, including the date of its expiration and the terms and conditions of its exercisability and transferability, shall be the same as the terms of the Exercised Option to which it relates,
except that (i) the grant date for each Reload Option shall be the date of exercise of the Exercised Option to which it relates and (ii) the exercise price for each Reload Option shall be the Fair Market Value of the Common Stock on the grant date
of the Reload Option. 
  
 7. Stock Appreciation Rights. 
  
 The Committee shall have the authority to grant SARs under this Plan, either
alone or to any optionee in tandem with Options (either at the time of grant of the related Option or thereafter by amendment to an outstanding Option). SARs shall be subject to such terms and conditions as the Committee may specify. 
  
 No SAR may be exercised unless the Fair Market Value of a share of Common
Stock of the Company on the date of exercise exceeds the exercise price of the SAR or, in the case of SARs granted in tandem with Options, any Options to which the SARs correspond. Prior to the exercise of the SAR and delivery of the cash and/or
Shares represented thereby, the Participant shall have no rights as a stockholder with respect to Shares covered by such outstanding SAR (including any dividend or voting rights). 
  
 In the case of SARs granted in tandem with Options: (i) such SARs shall be exercisable only when, to the extent and on the
conditions that any related Option is exercisable, and (ii) the exercise of an Option shall result in an immediate forfeiture of any related SAR to the extent the Option is exercised, and the exercise of an SAR shall cause an immediate forfeiture of
any related Option to the extent the SAR is exercised. 
  
 Upon
the exercise of an SAR, the Participant shall be entitled to a distribution in an amount equal to the difference between the Fair Market Value of a share of Common Stock on the date of exercise and the exercise price of the SAR or, in the case of
SARs granted in tandem with Options, any Option to which the SAR is related, multiplied by the number of Shares as to which the SAR is exercised. The Committee shall decide whether such distribution shall be in cash, in Shares having a Fair Market
Value equal to such amount, in Other Company Securities having a Fair Market Value equal to such amount or in a combination thereof. 
  
 All SARs will be exercised automatically on the last day prior to the expiration date of the SAR or, in the case of SARs granted in tandem with Options,
any related Option, so long as the Fair Market Value of a share of Common Stock on that date exceeds the exercise price of the SAR or any related Option, as applicable. An SAR 

  

 11 

 
granted in tandem with Options shall expire at the same time as any related Option expires and shall be transferable only when, and under the same conditions
as, any related Option is transferable. 
  
 Each SAR shall be
subject to the vesting, termination and forfeiture provisions set forth in Section 6(e). 
  
 8. Restricted Stock Shares; Restricted Stock Units. 
  
 The Committee may at any time and from time to time grant restricted stock shares or restricted stock units under the Plan to such Participants and in such amounts as it determines. Each grant of restricted stock
shares or restricted stock units shall be evidenced by a Grant Agreement which shall specify the applicable restrictions on such shares or units, the duration of such restrictions (which shall be at least six months except as otherwise determined by
the Committee), and the time or times at which such restrictions shall lapse with respect to all or a specified number of shares or units that are part of the grant. 
  
 Each restricted stock unit shall be equivalent in value to one share of Common Stock and shall entitle the Participant to
receive from the Company at the end of the vesting period applicable to such unit, one Share for each restricted stock unit. Restricted stock units may be granted without payment of cash or other consideration to the Company; provided, however, that
Participants will be required to pay the Company the aggregate par value of the Shares received from the Company when such Shares are issued unless such Shares are treasury shares. 
  
 A Participant’s Grant Agreement may allow the Participant to elect prior to the end of the applicable vesting period to
defer the receipt of all or a portion of the Shares then due with respect to vesting restricted stock units. Upon such deferral, the restricted stock units so deferred shall be converted into deferred stock units. Delivery of Shares with respect to
deferred stock units shall be made only at the end of the deferral period set forth in the Participant’s deferral election notice (the “Deferral Period”). Unless otherwise provided in a Participant’s Grant Agreement, if (a) a
Participant dies prior to the end of the Deferral Period, the Participant shall receive Shares in respect of such Participant’s deferred stock units which would have been deliverable at the end of such Deferral Period as if the applicable
Deferral Period had ended as of the date of such Participant’s death or on such accelerated basis as the Committee may determine, (b) if a Participant ceases to be a director, officer or employee of, or to otherwise perform services for, the
Company and its Subsidiaries upon his or her Disability or Retirement or for any other reason prior to the end of the Deferral Period, the Participant shall receive Shares in respect of such Participant’s deferred stock units at the end of such
Deferral Period, and (c) in the event of a Change in Control prior to the end of the Deferral Period, the Participant shall receive Shares in respect of such Participant’s deferred stock units which would have been deliverable at the end of
such Deferral Period as if such Deferral Period had ended immediately prior to the Change in Control. 
  

 12 

 The Participant will be required to pay the Company the aggregate par value of any restricted stock
shares within ten days of the date of grant of such shares, unless such restricted stock shares are treasury shares. Unless otherwise determined by the Committee, certificates representing restricted stock shares granted under the Plan will be held
in escrow by the Company on the Participant’s behalf during any period of restriction thereon and will bear an appropriate legend specifying the applicable restrictions thereon, and the Participant will be required to execute a blank stock
power therefor. 
  
 Except as otherwise provided in any Grant
Agreement, upon a Change in Control or at such time as a Participant ceases to be a director, officer or employee of, or to otherwise perform services for, the Company or its Subsidiaries due to death, Disability or Retirement during any period of
restriction, all restrictions on restricted stock shares or restricted stock units granted to such Participant shall lapse. In addition, the Committee shall have the authority to grant restricted stock shares and restricted stock units and other
Awards that: (i) do not fully vest and become exercisable automatically upon a Change in Control, (ii) vest depending on whether or not the grantee is terminated after or upon a Change in Control, and (iii) provide for accelerated vesting after a
Change in Control if certain conditions are met or certain events take place. The Committee shall also have the authority to modify the definition of “Change in Control” for purposes of any Grant Agreement. Except as otherwise provided in
any Grant Agreement, at such time as a Participant ceases to be, or in the event a Participant does not become, a director, officer or employee of, or otherwise perform services for, the Company or its Subsidiaries for any reason other than those
set forth in the immediately preceding sentence (including, without limitation, discharge for Cause), all restricted stock shares and restricted stock units granted to such Participant on which the restrictions have not lapsed shall be immediately
forfeited to the Company. 
  
 With respect to restricted stock
shares, during such period of restriction the Participant shall have all of the rights of a holder of Common Stock, including but not limited to the rights to receive dividends and to vote, and any stock or other securities received as a
distribution with respect to such Participant’s restricted stock shares shall be subject to the same restrictions as then in effect for the restricted stock shares. With respect to the restricted stock units, during such period of restriction
the Participant shall not have any rights as a shareholder of the Company; provided that, unless otherwise provided in a Participant’s Grant Agreement, the Participant shall have the right to receive accumulated dividends or distributions with
respect to the corresponding number of Shares underlying each restricted stock unit on the date of its full vesting and thereafter until the underlying Shares are issued, including after any such restricted stock units are converted into deferred
stock units. 
  
 9. Performance Awards. 
  
 Performance awards may be granted to Participants at any time and from time
to time as determined by the Committee. The Committee shall have complete discretion in determining the size and composition of performance awards granted to a 

  

 13 

 
Participant and the appropriate period over which performance is to be measured (a “performance cycle”). Performance awards may include (i)
specific dollar-value target awards, (ii) performance units, the value of each such unit being determined by the Committee at the time of issuance, and/or (iii) performance shares, the value of each such share being equal to the Fair Market Value of
a share of Common Stock. 
  
 The value of each performance award
may be fixed or it may be permitted to fluctuate based on a performance factor (e.g., return on equity) selected by the Committee. 
  
 The Committee shall establish performance goals and objectives for each performance cycle on the basis of such criteria and objectives as the Committee
may select from time to time, including, without limitation, the performance of the Participant, the Company, one or more of its Subsidiaries or divisions or any combination of the foregoing. During any performance cycle, the Committee shall have
the authority to adjust the performance goals and objectives for such cycle for such reasons as it deems equitable. 
  
 The Committee shall determine the portion of each performance award that is earned by a Participant on the basis of the Company’s performance over
the performance cycle in relation to the performance goals for such cycle. The earned portion of a performance award may be paid out in Shares, cash, Other Company Securities, or any combination thereof, as the Committee may determine. 

 
 A Participant must be a director, officer or employee of, or otherwise
perform services for, the Company or its Subsidiaries at the end of the performance cycle in order to be entitled to payment of a performance award issued in respect of such cycle; provided, however, that except as otherwise determined by the
Committee, if a Participant ceases to be a director, officer or employee of, or to otherwise perform services for, the Company and its Subsidiaries upon his or her death, Retirement, or Disability prior to the end of the performance cycle, the
Participant shall earn a proportionate portion of the performance award based upon the elapsed portion of the performance cycle and the Company’s performance over that portion of such cycle. 
  
 Unless otherwise provided in any Grant Agreement, in the event of a Change in
Control, a Participant shall earn no less than the portion of the performance award that the Participant would have earned if the applicable performance cycle(s) had terminated as of the date of the Change in Control. 
  
 10. Withholding Taxes. 
  
 (a) Participant Election. Unless otherwise determined by the Committee, a Participant may elect to deliver shares of
Common Stock (or have the Company withhold shares acquired upon the exercise of an Option or a SAR or deliverable upon a grant of restricted stock shares or the vesting of restricted stock units or the receipt of shares of Common Stock for any other
reason hereunder, as the case may 

  

 14 

 
be) to satisfy, in whole or in part, the amount the Company is required to withheld for taxes in connection with the exercise of an Option or a SAR, the
delivery or vesting of restricted stock shares, the vesting of restricted stock units or the vesting or receipt of shares of Common Stock for any other reason hereunder, as the case may be. Such election must be made on or before the date the amount
of tax to be withheld is determined. Once made, the election shall be irrevocable. The fair market value of the shares to be withheld or delivered will be the Fair Market Value as of the date the amount of tax to be withheld is determined. In the
event a Participant elects to deliver or have the Company withhold shares of Common Stock pursuant to this Section 10(a), such delivery or withholding must be made subject to the conditions and pursuant to the procedures set forth in
Section 6(b) with respect to the delivery or withholding of Common Stock in payment of the exercise price of Options. 
  
 (b) Company Requirement. The Company may require, as a condition to any grant, vesting or exercise under the Plan or to the delivery of
certificates for Shares issued hereunder, that the grantee make provision for the payment to the Company, either pursuant to Section 10(a) or this Section 10(b), of federal, state or local taxes of any kind required by law to be
withheld with respect to any grant, vesting, delivery or issuance of Shares, Options, SARs, restricted stock units, performance awards or any other Award granted under the Plan. The Company, to the extent permitted or required by law, shall have the
right to deduct from any payment of any kind (including salary or bonus) otherwise due to a grantee, an amount equal to any federal, state or local taxes of any kind required by law to be withheld with respect to any grant, vesting, delivery or
issuance of Shares, Options, SARs, restricted stock units, performance awards, or any other Award granted under the Plan. 
  
 11. Grant Agreement; Vesting. 
  
 Each employee to whom an Award is made under the Plan shall enter into a Grant Agreement with the Company that shall contain such provisions, including,
without limitation, vesting requirements, consistent with the provisions of the Plan, as may be approved by the Committee. Unless the Committee determines otherwise or as otherwise provided in Section 6, Section 7, Section 8,
and Section 9 in connection with a Change in Control or certain occurrences of termination, no Award under this Plan may be exercised, and no restrictions relating thereto may lapse, within six months of the date such Award is made.

  
 12. Transferability. 
  
 Unless otherwise provided in any Grant Agreement, no Award granted under the
Plan shall be transferable by a Participant other than by will or the laws of descent and distribution or to a Participant’s Family Member by gift or a qualified domestic relations order as defined by the Code. Unless otherwise provided in any
Grant Agreement, an Option may be exercised only by the optionee or grantee thereof; by his or her Family Member if such person has acquired the option by gift or qualified domestic relations order; by the executor or administrator of the estate of
any of the foregoing or 

  

 15 

 
any person to whom the Option is transferred by will or the laws of descent and distribution; or by the guardian or legal representative of any of the
foregoing; provided that, Incentive Stock Options may be exercised by any Family Member, guardian or legal representative only if permitted by the Code and any regulations thereunder. All provisions of this Plan shall in any event continue to apply
to any Award granted under the Plan and transferred as permitted by this Section 12, and any transferee of any such Award shall be bound by all provisions of this Plan as and to the same extent as the applicable original grantee. 

 
 13. Listing, Registration and Qualification. 
  
 If the Committee determines that the listing, registration or qualification
upon any securities exchange or under any law of Shares subject to any Award is necessary or desirable as a condition of, or in connection with, the granting of such Award or the delivery, issuance or purchase of Shares thereunder, no such Option
may be exercised in whole or in part, no such restricted stock unit may be converted into Shares, and no Shares may be delivered, issued or purchased, unless such listing, registration or qualification is effected free of any conditions not
acceptable to the Committee. 
  
 14. Transfer of Employee; Employment by
Subsidiary. 
  
 The transfer of an employee from the Company
to a Subsidiary, from a Subsidiary to the Company, or from one Subsidiary to another Subsidiary shall not be considered a termination of employment; nor shall it be considered a termination of employment if an employee is placed on military or sick
leave or such other leave of absence which is considered by the Committee as continuing intact the employment relationship; provided, however, if a Subsidiary ceases to be a “Subsidiary” (as defined in Section 2 hereof) for any reason, the
employment of the employees of such former Subsidiary shall be considered to be terminated at such time for purposes of the Plan and any Awards. 
  
 15. No Corporate Action Restriction; Adjustments. 
  
 The existence of the Plan, any Grant Agreement and/or the Awards granted hereunder shall not limit, affect or restrict in any way the right or power of
the Board or the shareholders of the Company to make or authorize (a) any adjustment, recapitalization, reorganization or other change in the Company’s or any subsidiary’s capital structure or business, (b) any merger, consolidation or
change in the ownership of the Company or any subsidiary, (c) any issue of bonds, debentures, capital, preferred or prior preference stocks ahead of or affecting the Company’s or any subsidiary’s capital stock or the rights thereof, (d)
any dissolution or liquidation of the Company or any subsidiary, (e) any sale or transfer of all or any part of the Company’s or any subsidiary’s assets or business, or (f) any other corporate act or proceeding by the Company or any
subsidiary. 
  

 16 

 In the event of any adjustment, recapitalization, reorganization or other change in the Company’s
capital structure, stock split, reverse stock split, stock dividend, combination of shares, merger, consolidation, distribution to stockholders of a material amount of assets of the Company (including in the form of an extraordinary dividend), or
any other change in the corporate structure or shares of the Company, the Committee shall make such equitable adjustments as it deems appropriate in the number and kind of Shares or other property available for issuance under the Plan (including,
without limitation, the total number of Shares available for issuance under the Plan pursuant to Section 4 and the restriction on the total number of Options and SARs that may be granted to any one Participant in any one calendar year under
Section 6), in the number and kind of Awards or other property covered by Awards previously made under the Plan, and in the exercise price of outstanding options or other Awards. Any such adjustment shall be final, conclusive and binding for
all purposes of the Plan. In the event of any merger, consolidation or other reorganization in which the Company is not the surviving or continuing corporation or in which a Change in Control is to occur, all of the Company’s obligations
regarding any Awards that were granted hereunder and that are outstanding on the date of such event shall, on such terms as may be approved by the Committee prior to such event, be assumed by the surviving or continuing corporation or canceled in
exchange for property (including cash). 
  
 Without limitation of
the foregoing, in connection with any transaction of the type specified by clause (iii) of the definition of a Change in Control in Section 2(e): (A) the Committee may cancel those outstanding vested or unvested Options under the Plan which
have a value in excess of their exercise price in consideration for payment to the holders thereof of an amount equal to the portion of the consideration, if any, that would have been payable to such holders pursuant to such transaction if such
Options had been fully exercised immediately prior to such transaction, less the aggregate exercise price of such Options that would have been payable therefor, or (B) if the amount that would have been payable to the holder of an Option if such
Option had been fully exercised immediately prior to such transaction would have been equal to or less than the exercise price of such Option, the Committee may cancel any or all such Options for no consideration or payment of any kind. Payment of
any amount payable pursuant to the preceding sentence may be made in cash or, in the event that the consideration to be received in such transaction includes securities or other property, in cash and/or such securities or other property in the
Committee’s discretion. 
  
 16. Amendment and Termination of Plan.

  
 The Board or the Committee, without approval of the
stockholders of the Company, may amend or terminate the Plan at any time, except that no amendment shall become effective without prior approval of the stockholders of the Company if (i) stockholder approval would be required by applicable law or
regulations, including if required by any listing requirement of the principal stock exchange or national market on which the Common Stock is then listed, (ii) such amendment would remove from the Plan a provision which, without giving effect to
such amendment, is subject to shareholder approval, or (iii) such amendment would directly or indirectly increase the 

  

 17 

 
Share limits set forth in Section 4 (except for amendments reflecting adjustments made pursuant to the provisions of Section 15). The
termination of the Plan shall not adversely affect any outstanding Awards under the Plan. 
  
 17. Amendment or Substitution of Awards under the Plan. 
  
 The terms of any outstanding Award under the Plan may be amended from time to time by the Committee in any manner that it deems appropriate (including,
but not limited to, acceleration of the date of exercise of any Award and/or payments thereunder or of the date of lapse of restrictions on Shares); provided that, except as otherwise provided in Section 15, (i) no amendment of the Plan or an
Award shall adversely affect in a material manner any right of a Participant under any Award without his or her written consent, and (ii) the Committee shall not reduce the exercise price of any Options awarded under the Plan without approval of the
stockholders of the Company. The Committee may, in its discretion, (A) permit holders of Awards under the Plan to surrender outstanding Awards in order to exercise or realize rights under other Awards, or in exchange for the grant of new Awards
under the Plan or otherwise, or (B) require holders of Awards to surrender outstanding Awards as a condition precedent to the grant of new Awards under the Plan or otherwise. 
  
 18. Commencement Date; Termination Date. 
  
 The date of commencement of the Plan shall be the Commencement Date. Unless previously terminated upon the adoption of a resolution of the Board
terminating the Plan, the Plan shall terminate at the close of business ten years after the Commencement Date. No termination of the Plan shall materially and adversely affect any of the rights or obligations of any person, without his or her
written consent, under any Award or other incentives theretofore granted under the Plan. 
  
 19. Severability. Whenever possible, each provision of the Plan shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of the Plan is held to be prohibited
by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of the Plan. 
  
 20. Governing Law. The Plan shall be governed by the corporate laws of the State of Delaware, without giving effect to any choice of
law provisions that might otherwise refer construction or interpretation of the Plan to the substantive law of another jurisdiction. 
  
 *    *    *    * 
  

 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]